COMPANY · NIPC 506760014

MUNDIPHARMA - FARMACÊUTICA, LDA.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €910,740.71 across 242 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameMUNDIPHARMA - FARMACÊUTICA, LDA.
NIPC506760014

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €62,115.6120122013: €601.122018: €216.3220182019: €225,910.672020: €392,331.5720202021: €48,614.532022: €41,252.4120222023: €61,742.632024: €20,152.7620242025: €34,706.582026: €23,096.512026€392,331.57
Contracted value by year
YearContractsContract value
20122€62,115.61
20132€601.12
20184€216.32
201938€225,910.67
202024€392,331.57
202129€48,614.53
202225€41,252.41
202326€61,742.63
202434€20,152.76
202534€34,706.58
202624€23,096.51
Contracted value by place of performance
NameContractsContract value
Faro23€214,413.82
Lisboa20€192,864.50
Setúbal3€66,772.85
Funchal8€65,207.34
Évora3€62,413.55
Porto13€18,545.26
Santa Maria da Feira6€6,741.93
Vila Nova de Gaia10€4,693.16
Viana do Castelo7€3,487.93
Almada11€3,297.13
Largest contracts
SubjectYearContract value
MEDICAMENTOS ANALGÉSICOS, ANTIPIRÉTICOS E ANTIDEPRESSIVOS 2018/44 ( ANO 2020 )2020€197,507.82
CPU n.o 191A000014 - Aquisição de pegfilgrastim inj. 6 mg - seringa2019€68,544
Aquisição de medicamentos diversos2012€61,861.77
FACT ESTIM MACRÓFAGO/ GRANULOCITOPOIESE2020€53,100
41/4102/2020 - Medicamento Pegfilgrastim 6 mg/0.6 ml Sol inj Ser 0.6 ml SC2020€48,000

Who they competed with

In 1,723 contracts with a list of competitors, the company took part and was awarded 123 (7%).

Companies with the most procedures in common
CompanyProcedures in common
generis125
labesfal,, SA123
overpharma122
sandoz117
mylan108
grunenthal103
b.braun101
Medinfar100
farmoz93
hikma89
unilfarma86
Zentiva, Lda.81
PLS Pharma, Produtos Farmacêuticos, Lda79
angelini78
korangi77
Fresenius Kabi Pharma, Lda.73
accord70
Sidefarma, S.A.59
DLA-Farmacêutica,SA.58
tecnifar51
RANGEL, PRODUTOS FARMACÊUTICOS, SA35
Tecnimede, SA33
Bluepharma Indústria Farmacêutica,S.A.32
kyowa32
pharmakern portugal31
glaxo29
Sanofi-Produtos Farmacêuticos22
Teva, Lda.21
Organon Portugal, Unipessoal Lda20
janssen18

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents37 companies and 60 links. The list below gives the same content as text.grunenthal (NIPC 500101965)grunenthaljanssen (NIPC 500189412)janssentecnifar (NIPC 500280436)tecnifarunilfarma (NIPC 500293023)unilfarmaMedinfar (NIPC 500384045)Medinfarangelini (NIPC 500583650)angeliniTecnimede, SA (NIPC 500626413)Tecnimede, SASidefarma, S.A. (NIPC 500717419)Sidefarma, S.A.labesfal,, SA (NIPC 501169580)labesfal,, SAfarmoz (NIPC 501505334)farmozNIPC 506760014 (NIPC 506760014)NIPC 506760014+26 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.